Abiopharma

The Gross Law Firm Reminds Integer Holdings Corporation Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 9, 2026 - ITGR

DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - DXCM

Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma

Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer

Enhertu granted BTD for post-neoadjuvant early BC

Update on LATIFY Phase III trial of ceralasertib

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Alvotech og Advanz Pharma hefja sölu í Evrópu á fyrstu hliðstæðunni við Simponi

Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma

Innate Pharma - Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025